Stimcell Energetics (STME) EBITDA Margin Growth (5y) (2021 - 2022)
Powered by 
Analysis
Stimcell Energetics (STME) EBITDA Margin Growth (5y) (2021 - 2022) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.91 Bn | 178.31 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 124.32 Bn | 119.11 Bn | 1.96 Bn |
| 3 | Medtronic | 118.42 Bn | 109.60 Bn | 6.34 Bn |
| 4 | Stryker | 105.22 Bn | 101.74 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.57 Bn | 66.03 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.76 Bn | 45.51 Bn | 1.35 Bn |
| 7 | Alcon | 33.91 Bn | 32.46 Bn | 1.68 Bn |
| 8 | Dexcom | 32.28 Bn | 30.33 Bn | 830.00 Mn |
| 9 | Steris | 21.10 Bn | 20.62 Bn | 684.20 Mn |
| 10 | Stimcell Energetics | 5.92 Mn | 5.92 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Feb 28, 2022 | 3.03 Mn |
| Nov 30, 2021 | 6.17 Mn |
| Aug 31, 2021 | -1.48 Mn |
| May 31, 2021 | 2.00 Mn |
| Feb 28, 2021 | 714,960.00 |